Cargando…

Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer’s disease

Beta-amyloid (Aβ) and tau proteins, the pathological hallmarks of Alzheimer’s disease (AD), are believed to spread through connected regions of the brain. Combining diffusion imaging and positron emission tomography, we investigated associations between white matter microstructure specifically in bu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pichet Binette, Alexa, Theaud, Guillaume, Rheault, François, Roy, Maggie, Collins, D Louis, Levin, Johannes, Mori, Hiroshi, Lee, Jae Hong, Farlow, Martin Rhys, Schofield, Peter, Chhatwal, Jasmeer P, Masters, Colin L, Benzinger, Tammie, Morris, John, Bateman, Randall, Breitner, John CS, Poirier, Judes, Gonneaud, Julie, Descoteaux, Maxime, Villeneuve, Sylvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169107/ https://www.ncbi.nlm.nih.gov/pubmed/33983116 http://dx.doi.org/10.7554/eLife.62929

Ejemplares similares

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease
por: Gonneaud, Julie, et al.
Publicado: (2021)

Tau accumulation and its spatial progression across the Alzheimer’s disease spectrum
por: St-Onge, Frédéric, et al.
Publicado: (2023)

Trait Mindfulness Is Associated With Less Amyloid, Tau, and Cognitive Decline in Individuals at Risk for Alzheimer’s Disease
por: Strikwerda-Brown, Cherie, et al.
Publicado: (2022)

Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease
por: Vogel, Jacob W, et al.
Publicado: (2018)

Modern Technology in Multi-Shell Diffusion MRI Reveals Diffuse White Matter Changes in Young Adults With Relapsing-Remitting Multiple Sclerosis
por: Beaudoin, Ann-Marie, et al.
Publicado: (2021)

Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer’s Disease
por: Tuwaig, Miranda, et al.
Publicado: (2017)

Odor identification as a biomarker of preclinical AD in older adults at risk
por: Lafaille-Magnan, Marie-Elyse, et al.
Publicado: (2017)

Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease
por: Tremblay-Mercier, Jennifer, et al.
Publicado: (2021)

No apparent effect of naproxen on CSF markers of innate immune activation
por: Meyer, Pierre‐François, et al.
Publicado: (2019)

Efficient Fmoc-Protected Amino Ester Hydrolysis Using Green Calcium(II) Iodide as a Protective Agent
por: Binette, Renaud, et al.
Publicado: (2022)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s disease
por: Salvadó, Gemma, et al.
Publicado: (2023)

Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease
por: Llibre-Guerra, Jorge J., et al.
Publicado: (2019)

Free water: A marker of age-related modifications of the cingulum white matter and its association with cognitive decline
por: Edde, Manon, et al.
Publicado: (2020)

The frontotemporal organization of the arcuate fasciculus and its relationship with speech perception in young and older amateur singers and non‐singers
por: Perron, Maxime, et al.
Publicado: (2021)

Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease
por: Picard, Cynthia, et al.
Publicado: (2021)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

TractoInferno - A large-scale, open-source, multi-site database for machine learning dMRI tractography
por: Poulin, Philippe, et al.
Publicado: (2022)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Functional connectome fingerprinting across the lifespan
por: St-Onge, Frédéric, et al.
Publicado: (2023)

Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer’s Disease
por: Konishi, Kyoko, et al.
Publicado: (2018)

Covariance-based vs. correlation-based functional connectivity dissociates healthy aging from Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis
por: Meyer, Pierre-François, et al.
Publicado: (2018)

High‐frequency longitudinal white matter diffusion‐ and myelin‐based MRI database: Reliability and variability
por: Edde, Manon, et al.
Publicado: (2023)

CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
por: Horie, Kanta, et al.
Publicado: (2023)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Circular RNA detection identifies circPSEN1 alterations in brain specific to autosomal dominant Alzheimer's disease
por: Chen, Hsiang-Han, et al.
Publicado: (2022)

Visualization, Interaction and Tractometry: Dealing with Millions of Streamlines from Diffusion MRI Tractography
por: Rheault, Francois, et al.
Publicado: (2017)

How can we really improve screening methods for AD prevention trials?
por: Breitner, John C.S.
Publicado: (2016)

Pharmacogenetic analysis of the effects of polymorphisms in APOE, IDE and IL1B on a ketone body based therapeutic on cognition in mild to moderate Alzheimer's disease; a randomized, double-blind, placebo-controlled study
por: Henderson, Samuel T, et al.
Publicado: (2011)

Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways
por: Elbert, Donald L., et al.
Publicado: (2022)

Diurnal Patterns of Soluble Amyloid Precursor Protein Metabolites in the Human Central Nervous System
por: Dobrowolska, Justyna A., et al.
Publicado: (2014)

Could Lipoprotein Lipase Play a Role in Alzheimer's Disease?
por: Blain, Jean-Francois, et al.
Publicado: (2004)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019)

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease
por: Lee, Seonjoo, et al.
Publicado: (2018)

Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network
por: Karch, Celeste M., et al.
Publicado: (2018)

Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum
por: Nilsson, Nathalie I. V., et al.
Publicado: (2021)

Microglia Implicated in Tauopathy in the Striatum of Neurodegenerative Disease Patients from Genotype to Phenotype
por: Li, Huifangjie, et al.
Publicado: (2020)

Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis
por: Tang, Mengxuan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qrfoor8qsqg35kscl43t2sc7ns